Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting

George E Ronson1, Katarzyna Starowicz1,2, Elizabeth J Anthony1

  • 1Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

Nature Communications
|November 29, 2023
PubMed

Insights

Synthetic lethality between polymerase theta (Polθ) loss and DNA repair defects (like BRCA1 or 53BP1 loss) depends on RAD52 and cell genotype. Polθ inhibition reveals distinct genotype-specific mechanisms underlying this synthetic lethality.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Synthetic lethality offers therapeutic strategies for cancer by exploiting dependencies between gene disruptions.
  • Polymerase theta (Polθ) plays a role in DNA repair, and its disruption shows synthetic letharilty with defects in 53BP1 or homologous recombination (HR) proteins like BRCA1.
  • The precise mechanisms driving these synthetic lethal interactions remain largely unelucidated.

Purpose of the Study:

  • To elucidate the distinct molecular mechanisms underlying the synthetic lethality between polymerase theta (Polθ) disruption and deficiencies in 53BP1 or BRCA1.
  • To investigate the influence of Polθ loss versus inhibition and the specific genetic background on these synthetic lethal phenotypes.

Main Methods:

  • Utilized cell-based assays to assess the sensitivity of BRCA1/2- and 53BP1-deficient cells to Polθ loss and inhibition (using ART558).
  • Investigated the role of RAD52 in mediating these synthetic lethal phenotypes.
  • Analyzed DNA single-stranded gap-filling processes and MRE11 nuclease accumulation in different genetic contexts.

Main Results:

  • Sensitivity to Polθ loss or inhibition in 53BP1-deficient cells, and Polθ loss in BRCA1/2-deficient cells, is dependent on RAD52.
  • RAD52 suppression can rescue synthetic lethality in 53BP1-deficient cells by preventing aberrant RAD52 accumulations and MRE11 nuclease activity.
  • In contrast, RAD52 suppression does not rescue BRCA1-deficient cells treated with a Polθ inhibitor, as the inhibited polymerase itself blocks DNA gap-filling.

Conclusions:

  • Identified two distinct mechanisms of Polθ synthetic lethality, dependent on whether Polθ is lost or inhibited, and the specific genotype.
  • Defined a novel role for Polθ in suppressing RAD52-mediated DNA repair intermediates.
  • These findings highlight genotype-specific mechanisms of Polθ inhibitor action and offer insights into targeted cancer therapies.

Related Concept Videos

Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.0K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
Proofreading01:31

Proofreading

Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore,  it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase...
6.3K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K